130 related articles for article (PubMed ID: 24513053)
1. 24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation.
Lancaster ST; Blackburn J; Blom A; Makishima M; Ishizawa M; Mansell JP
Steroids; 2014 May; 83():52-61. PubMed ID: 24513053
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid, human osteoblast formation, maturation and the role of 1α,25-Dihydroxyvitamin D3 (calcitriol).
Mansell JP; Blackburn J
Biochim Biophys Acta; 2013 Jan; 1831(1):105-8. PubMed ID: 22561288
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeletal reorganisation, 1alpha,25-dihydroxy vitamin D3 and human MG63 osteoblast maturation.
Mansell JP; Farrar D; Jones S; Nowghani M
Mol Cell Endocrinol; 2009 Jun; 305(1-2):38-46. PubMed ID: 19433260
[TBL] [Abstract][Full Text] [Related]
4. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
5. The synergistic effects of lysophosphatidic acid receptor agonists and calcitriol on MG63 osteoblast maturation at titanium and hydroxyapatite surfaces.
Mansell JP; Barbour M; Moore C; Nowghani M; Pabbruwe M; Sjostrom T; Blom AW
Biomaterials; 2010 Jan; 31(2):199-206. PubMed ID: 19796809
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093).
Ryhänen S; Jääskeläinen T; Saarela JT; Mäenpää PH
J Cell Biochem; 1998 Sep; 70(3):414-24. PubMed ID: 9706878
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D
Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105
[TBL] [Abstract][Full Text] [Related]
8. Chitinase 3-like 1 expression by human (MG63) osteoblasts in response to lysophosphatidic acid and 1,25-dihydroxyvitamin D3.
Mansell JP; Cooke M; Read M; Rudd H; Shiel AI; Wilkins K; Manso M
Biochimie; 2016; 128-129():193-200. PubMed ID: 27575987
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.
Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA
Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid cooperates with 1alpha,25(OH)2D3 in stimulating human MG63 osteoblast maturation.
Gidley J; Openshaw S; Pring ET; Sale S; Mansell JP
Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):46-61. PubMed ID: 16846786
[TBL] [Abstract][Full Text] [Related]
11. Lithocholate--a promising non-calcaemic calcitriol surrogate for promoting human osteoblast maturation upon biomaterials.
Mansell JP; Shorez D; Farrar D; Nowghani M
Steroids; 2009 Nov; 74(12):963-70. PubMed ID: 19646460
[TBL] [Abstract][Full Text] [Related]
12. An N-Cyanoamide Derivative of Lithocholic Acid Co-Operates with Lysophosphatidic Acid to Promote Human Osteoblast (MG63) Differentiation.
Mansell JP; Tanatani A; Kagechika H
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509149
[TBL] [Abstract][Full Text] [Related]
13. Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D
Yang D; Anderson PH; Wijenayaka AR; Barratt KR; Triliana R; Stapledon CJM; Zhou H; Findlay DM; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2018 Mar; 177():83-90. PubMed ID: 28887147
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA.
Mansell JP; Nowghani M; Pabbruwe M; Paterson IC; Smith AJ; Blom AW
Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):45-52. PubMed ID: 21664483
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts.
Lisse TS; Chun RF; Rieger S; Adams JS; Hewison M
J Bone Miner Res; 2013 Jun; 28(6):1478-88. PubMed ID: 23362149
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5.
Yang D; Turner AG; Wijenayaka AR; Anderson PH; Morris HA; Atkins GJ
Mol Cell Endocrinol; 2015 Sep; 412():140-7. PubMed ID: 26054750
[TBL] [Abstract][Full Text] [Related]
17. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
19. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).
Ismail A; Nguyen CV; Ahene A; Fleet JC; Uskokovic MR; Peleg S
Mol Endocrinol; 2004 Apr; 18(4):874-87. PubMed ID: 14726489
[TBL] [Abstract][Full Text] [Related]
20. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
